Medical/Pharmaceuticals
Registrational Phase III CLARIFY trial in prostate cancer commences
SYDNEY, Nov. 30, 2023 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce it has commenced its r...
2023-11-30 22:16
1470
Lunit to Advance Singapore's Healthcare System with AI-powered Solution for Medical Imaging
* Lunit INSIGHT CXR is piloted at Singapore General Hospital and Changi General Hospital through AimSG, a national medical imaging AI platform for Singapore's Public Healthcare SEOUL, South Korea, Nov. 30, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions fo...
2023-11-30 22:10
1936
NCCN and SLACOM Host International Symposium to Improve Breast Cancer Care in Latin America
Experts from across Latin America explore how to improve access to recommended treatment practices based on the latest international guidelines. BUENOS AIRES, Argentina and PLYMOUTH MEETING, Pa., Nov. 30, 2023 /PRNewswire/ -- Today the Latin American and Caribbean Society of Medical Oncology (SLA...
2023-11-30 22:04
1306
First patient with metastatic prostate cancer to receive 2 doses of Cu-67 SAR-bisPSMA achieves undetectable PSA level
HIGHLIGHTS * Undetectable levels of Prostate Specific Antigen (PSA) have been reported from the first patient with metastatic castrate-resistant prostate cancer (mCRPC) to ever receive two cycles of Clarity's67Cu-SAR-bisPSMA at the 8GBq dose level. PSA is a marker of tumour burden, clinical re...
2023-11-30 21:59
1622
Innovent's MSCI ESG Rating Upgraded to A
ROCKVILLE, Md. and SUZHOU, China, Nov. 30, 2023 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and ...
2023-11-30 21:37
7255
Scantox acquires QPS Austria's Neuropharmacology Division
EJBY, Denmark, Nov. 30, 2023 /PRNewswire/ -- Today Scantox, together with its majority owner Impilo, has agreed to acquire the neuropharmacology division of QPS Austria GmbH ("QPS Neuro" or "the Company") ultimately owned by QPS Holdings LLC. QPS Neuro is a leading drug discovery Contract Researc...
2023-11-30 21:00
1872
The Best Class 4 Laser Therapy Machine Takes Center Stage at The 55th Dusseldorf International Hospital and Medical Equipment Exhibition in 2023
DUSSELDORF, Germany, Nov. 30, 2023 /PRNewswire/ -- Rhein Laser Technologies Ltd., a prominent manufacturer specializing in innovative medical lasers for aesthetic and physiotherapy markets with operations inWuhan and Dusseldorf, has garnered widespread acclaim and attention from industry professi...
2023-11-30 20:40
1334
UroFiber SuperPulsed Thulium Fiber Laser System Officially Debuts at MEDICA 2023
DUSSELDORF, Germany, Nov. 30, 2023 /PRNewswire/ -- UroFiber SuperPulsed Thulium
Fiber Laser System
2023-11-30 20:30
1169
Peptone and The Institute of Oncology Research (IOR) Bellinzona Announce Collaborative Research Agreement
Collaboration focused on novel target discovery in prostate cancer LONDON and BELLINZONA, Switzerland, Nov. 30, 2023 /PRNewswire/ -- Peptone, a leader in translational biophysics and the design of novel therapeutics against intrinsically disordered proteins (IDPs), and The Institute of Oncology ...
2023-11-30 20:00
1369
SyntheticMR and Philips Announce Expanded Global Partnership for SyMRI 3D
LINKÖPING, Sweden, Nov. 30, 2023 /PRNewswire/ -- SyntheticMR announced today that they have expanded their partnership with Philips to include SyMRI 3D. The expanded agreement between Philips and SyntheticMR means that SyMRI 3D will be included in Philips' global price book once the relevant reg...
2023-11-30 17:43
1367
Triple Negative Breast Cancer: Expert Consensus on Local Treatment Options
Hong Kong Breast Cancer Foundation Launches "Immunotherapy Drug Financial Assistance Programme" to Benefit Patients in Need HONG KONG, Nov. 30, 2023 /PRNewswire/ -- Breast cancer is the leading cancer facing women inHong Kong. According to the statistics released by the Hong Kong Cancer Registry...
2023-11-30 15:00
1401
111, Inc. Announces Third Quarter 2023 Unaudited Financial Results
SHANGHAI, Nov. 30, 2023 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, today announced its unaudited financial results for the third quart...
2023-11-30 14:00
3979
Philips Future Health Index 2023 Report: Singapore's healthcare sector at the forefront of digital technology adoption to tackle staff shortages and improve efficiency
* 75% of healthcare leaders (vs 56% globally) in Singapore are already using, or planning to use, digital health technology to reduce the impact of healthcare workforce shortages. * A hospital/facility being at the forefront of AI is an important consideration by younger healthcare profession...
2023-11-30 10:30
1843
Awareness, Accessibility, and Affordability are Crucial for the Early Detection of Thalassemia
- Dr. Zhiyu Peng, Deputy GM at BGI Genomics, Head of the World Hemoglobinopathy Foundation, and Dr.Androulla Eleftheriou, Executive Director at TIF, analyze findings from the Global 2023 State of Thalassemia Awareness Report BANGKOK, Nov. 30, 2023 /PRNewswire/ -- Thalassemia, a hereditary hemogl...
2023-11-30 08:08
2366
Everest Medicines Announces Acceptance of Nefecon® New Drug Applications for the Treatment of Primary IgA Nephropathy in Adult Patients in South Korea
SHANGHAI, Nov. 30, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced today that its New Drug Application (NDA) for Nefecon®...
2023-11-30 07:25
3424
ShiraTronics Announces Groundbreaking Milestone: World's First Trial Phase Procedures for their Chronic Migraine Therapy System in Australian Pilot Study
MINNEAPOLIS, Nov. 30, 2023 /PRNewswire/ -- ShiraTronics, Inc., a pioneering medical device company, today announced the initiation of its groundbreaking RELIEV-CM pilot study inAustralia, marking the world's first seven patients' successful completion of trial phase procedures for their Chronic M...
2023-11-30 07:12
1302
Phase II OPALESCENCE Study of TLX250-CDx in Triple Negative Breast Cancer to be Presented at SABCS
MELBOURNE, Australia, Nov. 30, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises that the completed Phase II OPALESCENCE investigator-initiated trial (IIT) of its carbonic anhydrase IX (CAIX)-targeting positron emission tomography (PET) imaging candid...
2023-11-30 04:15
1606
Unither Pharmaceuticals celebrates 30 years of innovation and expertise
PARIS, Nov. 30, 2023 /PRNewswire/ -- Unither Pharmaceuticals, a leading CDMO (Contract Development and Manufacturing Organization), celebrates 30 years in business. In 1993, Unither Pharmaceuticals began operations by acquiring a 17-man pharmaceutical plant that produced 3 pharmaceutical forms. T...
2023-11-30 02:42
2069
Clarity's theranostic prostate cancer trial progresses at the highest dose level cohort
HIGHLIGHTS * Cohort 3 of the theranostic SECuRE trial investigating 64Cu/67 Cu-SAR-bisPSMA in metastatic castrate-resistant prostate cancer (mCRPC) has enrolled and treated 3 participants who received therapy with67Cu-SAR-bisPSMA at the highest dose level of 12GBq. * No dose limiting toxicit...
2023-11-29 21:58
1536
China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device
HAIKOU, China, Nov. 29, 2023 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma", or the "Company"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that its Dry Eye Disease (DED) therape...
2023-11-29 21:00
3256
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
9271
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
7748